322 related articles for article (PubMed ID: 27297500)
1. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group.
Cash T; McIlvaine E; Krailo MD; Lessnick SL; Lawlor ER; Laack N; Sorger J; Marina N; Grier HE; Granowetter L; Womer RB; DuBois SG
Pediatr Blood Cancer; 2016 Oct; 63(10):1771-9. PubMed ID: 27297500
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.
Applebaum MA; Worch J; Matthay KK; Goldsby R; Neuhaus J; West DC; Dubois SG
Cancer; 2011 Jul; 117(13):3027-32. PubMed ID: 21692057
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol.
Salah S; Abuhijla F; Ismail T; Yaser S; Sultan I; Halalsheh H; Shehadeh A; Abdelal S; Almousa A; Jaber O; Abu-Hijlih R
Clin Transl Oncol; 2020 Jun; 22(6):878-883. PubMed ID: 31429039
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.
Takenaka S; Naka N; Obata H; Joyama S; Hamada K; Imura Y; Kakunaga S; Aoki Y; Ueda T; Araki N; Yoshikawa H
Jpn J Clin Oncol; 2016 Jun; 46(6):522-8. PubMed ID: 27008849
[TBL] [Abstract][Full Text] [Related]
5. Extraskeletal versus Skeletal Ewing Sarcoma in the adult population: Controversies in care.
Lynch AD; Gani F; Meyer CF; Morris CD; Ahuja N; Johnston FM
Surg Oncol; 2018 Sep; 27(3):373-379. PubMed ID: 30217290
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.
Applebaum MA; Goldsby R; Neuhaus J; DuBois SG
Pediatr Blood Cancer; 2012 Oct; 59(4):617-20. PubMed ID: 22184129
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ;
Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of outcome and prognostic factors in extraosseous Ewing sarcoma.
Biswas B; Shukla NK; Deo SV; Agarwala S; Sharma DN; Vishnubhatla S; Bakhshi S
Pediatr Blood Cancer; 2014 Nov; 61(11):1925-31. PubMed ID: 25132242
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical features and outcomes in patients with extraskeletal vs skeletal Ewing sarcoma: an SEER database analysis of 3,178 cases.
Jiang S; Wang G; Chen J; Dong Y
Cancer Manag Res; 2018; 10():6227-6236. PubMed ID: 30538569
[TBL] [Abstract][Full Text] [Related]
10. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
[TBL] [Abstract][Full Text] [Related]
11. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.
Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ
Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653
[TBL] [Abstract][Full Text] [Related]
12. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.
Paulussen M; Ahrens S; Burdach S; Craft A; Dockhorn-Dworniczak B; Dunst J; Fröhlich B; Winkelmann W; Zoubek A; Jürgens H
Ann Oncol; 1998 Mar; 9(3):275-81. PubMed ID: 9602261
[TBL] [Abstract][Full Text] [Related]
13. Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.
Ahmed SK; Randall RL; DuBois SG; Harmsen WS; Krailo M; Marcus KJ; Janeway KA; Geller DS; Sorger JI; Womer RB; Granowetter L; Grier HE; Gorlick RG; Laack NNI
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1286-1294. PubMed ID: 28964585
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Latino and non-Latino patients with Ewing sarcoma.
Sharib J; Horvai A; Gray Hazard FK; Daldrup-Link H; Goldsby R; Marina N; DuBois SG
Pediatr Blood Cancer; 2014 Feb; 61(2):233-7. PubMed ID: 23970433
[TBL] [Abstract][Full Text] [Related]
15. Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group.
Lerman DM; Monument MJ; McIlvaine E; Liu XQ; Huang D; Monovich L; Beeler N; Gorlick RG; Marina NM; Womer RB; Bridge JA; Krailo MD; Randall RL; Lessnick SL;
Pediatr Blood Cancer; 2015 May; 62(5):759-65. PubMed ID: 25464386
[TBL] [Abstract][Full Text] [Related]
16. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.
Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K
Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma.
Boyce-Fappiano D; Guadagnolo BA; Ratan R; Wang WL; Wagner MJ; Patel S; Livingston JA; Lin PP; Diao K; Mitra D; Farooqi A; Lazar AJ; Roland CL; Bishop AJ
Oncologist; 2021 Mar; 26(3):250-260. PubMed ID: 33289298
[TBL] [Abstract][Full Text] [Related]
18. Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS).
Koscielniak E; Sparber-Sauer M; Scheer M; Vokuhl C; Kazanowska B; Ladenstein R; Niggli F; Ljungman G; Paulussen M; Bielack SS; Seitz G; Fuchs J; Hallmen E; Klingebiel T; On Behalf Of The Cws Study Group
Pediatr Blood Cancer; 2021 Oct; 68(10):e29145. PubMed ID: 34089219
[TBL] [Abstract][Full Text] [Related]
19. Identification of Discrete Prognostic Groups in Ewing Sarcoma.
Karski EE; McIlvaine E; Segal MR; Krailo M; Grier HE; Granowetter L; Womer RB; Meyers PA; Felgenhauer J; Marina N; DuBois SG
Pediatr Blood Cancer; 2016 Jan; 63(1):47-53. PubMed ID: 26257296
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.
Friedman DN; Chastain K; Chou JF; Moskowitz CS; Adsuar R; Wexler LH; Chou AJ; DeRosa A; Candela J; Magnan H; Pun S; Kahan T; Wolden SL; Meyers PA; Oeffinger KC
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
